title: [Continuing increase in the incidence of serogroup C meningococcal disease. Should we decide to vaccinate?].
authors.forename: J A
authors.initials: JA
authors.lastname: Soult Rubio
authors.forename: M
authors.initials: M
authors.lastname: Muñoz Sáez
authors.forename: J D
authors.initials: JD
authors.lastname: López Castilla
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez Becerra
authors.forename: A
authors.initials: A
authors.lastname: Romero Parreño
authors.forename: A
authors.initials: A
authors.lastname: Tovaruela Santos
mesh_terms: D002648:Child; D006801:Humans; D015994:Incidence; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D009345:Neisseria meningitidis / Q000145:classification; D012703:Serotyping
chemical_list: D022401:Meningococcal Vaccines
vernacular_title: Continúa aumentando la incidencia de enfermedad meningocócica por serogupo C. Debemos tomar la decisión de vacunar?